The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benoit, P.
Right arrow Articles by Meyer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benoit, P.
Right arrow Articles by Meyer, F.

The Journal of Immunology, Vol 150, Issue 3 707-716, Copyright © 1993 by American Association of Immunologists


ARTICLES

A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor

P Benoit, D Maguire, I Plavec, H Kocher, M Tovey and F Meyer
Laboratoire d'Oncologie Virale, UPR 274 CNRS-IRSC, Villejuif, France.

A cDNA encoding a 63-kDa human IFN-alpha R (hIFN-alpha R) has recently been cloned. Mouse cells transfected with this cDNA failed to show any signal transmission for IFN-beta, suggesting the involvement of additional chains in the receptor complex. We have expressed in Escherichia coli and COS 7 cells a soluble recombinant protein (sIFN- alpha R) comprising the extracellular domain of the hIFN-alpha R fused at the carboxyl terminus to a sequence of five histidine residues. The sIFN-alpha R was affinity purified and used to generate mAb. One mAb, 64G12, which recognized the cellular receptor as well as the recombinant proteins was found to neutralize the biologic activity of IFN-alpha, -beta, and -omega and natural type I IFN, but not IFN-gamma. To our knowledge, this is the first report of a neutralizing mAb against the human IFN-alpha R. Interestingly, we found that the affinity of this antibody for the cellular receptor depended on the cell line used. These results provide strong evidence that the cloned hIFN-alpha R chain is required for binding and signal transmission of all subspecies of type I IFN and suggest a structural heterogeneity of the receptor at the cell surface.


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M C Dall'Era, P M Cardarelli, B T Preston, A Witte, and J C Davis Jr
Type I interferon correlates with serological and clinical manifestations of SLE
Ann Rheum Dis, December 1, 2005; 64(12): 1692 - 1697.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Gauzzi, I. Canini, P. Eid, F. Belardelli, and S. Gessani
Loss of Type I IFN Receptors and Impaired IFN Responsiveness During Terminal Maturation of Monocyte-Derived Human Dendritic Cells
J. Immunol., September 15, 2002; 169(6): 3038 - 3045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lu, A. Chuntharapai, J. Beck, S. Bass, A. Ow, A. M. De Vos, V. Gibbs, and K. J. Kim
Structure-Function Study of the Extracellular Domain of the Human IFN-{alpha} Receptor (hIFNAR1) Using Blocking Monoclonal Antibodies: The Role of Domains 1 and 2
J. Immunol., February 15, 1998; 160(4): 1782 - 1788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Domanski, O. W. Nadeau, L. C. Platanias, E. Fish, M. Kellum, P. Pitha, and O. R. Colamonici
Differential Use of the beta L Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNalpha 2 and IFNbeta
J. Biol. Chem., February 6, 1998; 273(6): 3144 - 3147.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. C. Gauzzi, G. Barbieri, M. F. Richter, G. Uze, L. Ling, M. Fellous, and S. Pellegrini
The amino-terminal region of Tyk2 sustains the level of interferon alpha  receptor 1, a component of the interferon alpha /beta  receptor
PNAS, October 28, 1997; 94(22): 11839 - 11844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Russell-Harde, H. Pu, M. Betts, R. N. Harkins, H. D. Perez, and E. Croze
Reconstitution of a High Affinity Binding Site for Type I Interferons
J. Biol. Chem., November 3, 1995; 270(44): 26033 - 26036.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ghislain, G. Sussman, S. Goelz, L. E. Ling, and E. N. Fish
Configuration of the Interferon-alpha/beta Receptor Complex Determines the Context of the Biological Response
J. Biol. Chem., September 15, 1995; 270(37): 21785 - 21792.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. R. Colamonici, L. C. Platanias, P. Domanski, R. Handa, K. C. Gilmour, M. O. Diaz, N. Reich, and P. Pitha-Rowe
Transmembrane Signaling by the alpha Subunit of the Type I Interferon Receptor Is Essential for Activation of the Jak Kinases and the Transcriptional Factor ISGF3
J. Biol. Chem., April 7, 1995; 270(14): 8188 - 8193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Cutrone and J. A. Langer
Identification of Critical Residues in Bovine IFNAR-1 Responsible for Interferon Binding
J. Biol. Chem., May 11, 2001; 276(20): 17140 - 17148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.